IL1F10 and rheumatoid arthritis: IL-38 may predominantly impact PBMCs or Mφ infiltration and the secretion of key cytokines and chemokines implicated in the Th17 pathway by these cells and thus, exert anti-inflammatory effects on RA (Figure 2).